Aquaporin-3 (AQP3) is a water channel expressed at the basolateral plasma m
embrane of kidney collecting-duct epithelial cells. The mouse AQP3 cDNA was
isolated and encodes a 292-amino acid water/glycerol-transporting glycopro
tein expressed in kidney, large airways, eye, urinary bladder, skin, and ga
strointestinal tract. The mouse AQP3 gene was analyzed, and AQP3 null mice
were generated by targeted gene disruption. The growth and phenotype of AQP
3 null mice were grossly normal except for polyuria. AQP3 deletion had litt
le eff ect on AQP1 or AQP4 protein expression but decreased AQP2 protein ex
pression particularly in renal cortex. Fluid consumption in AQP3 null mice
was more than 10-fold greater than that in wild-type litter mates, and urin
e osmolality (<275 milliosmol) was much lower than in wild-type mice (>1,20
0 milliosmol), After 1-desamino-8-D-arginine-vasopressin administration or
water deprivation, the AQP3 null mice were able to concentrate their urine
partially to approximate to 30% of that in wild-type mice. Osmotic water pe
rmeability of cortical collecting-duct basolateral membrane, measured by a
spatial filtering optics method, was > 3-fold reduced by AQP3 deletion. To
test the hypothesis that the residual concentrating ability of AQP3 null mi
ce was due to the inner medullary collecting-duct water channel AQP4 AQP3/A
QP4 double-knockout mice were generated. The double-knockout mice had great
er impairment of urinary-concentrating ability than did the AQP3 single-kno
ckout mice. Our findings establish a form of nephrogenic diabetes insipidus
produced by impaired water permeability in collecting-duct basolateral mem
brane. Basolateral membrane aquaporins may thus provide blood-accessible ta
rgets for drug discovery of aquaretic inhibitors.